Holly Fraser discusses new findings on whether and how we can predict antidepressant response using artificial intelligence.
[read the full story...]Predicting antidepressant response using artificial intelligence
No Responses »
Digital self-help for bulimia recovery: encouraging results for waiting list management
In her debut blog, Ana Julia Ferreira summarises a randomised controlled trial investigating the effectiveness of a digital self-help intervention for improving bulimic-spectrum disorder symptomatology while on a treatment waiting list.
[read the full story...]The great unknown? Assessing suicide risk in trials of psychological interventions for depression
Derek de Beurs explores a meta-analysis which finds that randomised controlled trials of psychological interventions for depression rarely report assessments of suicide.
[read the full story...]Digitally augmented CBT for child anxiety is more efficient and no less effective than typical parent-led CBT
Helen Dodd summarises a recent non-inferiority randomised controlled trial led by Cathy Creswell, which investigated the effectiveness of digitally augmented parent-led CBT for child anxiety.
[read the full story...]Digital CBT can help people with depression or anxiety and comorbid long-term medical conditions
Stephanie Loukieh summarises the COMPASS trial, which presents promising results for digitally delivered CBT for depression and anxiety related to living with a long-term physical health condition.
[read the full story...]Is brief text messaging effective to reduce repeat hospital-treated self-harm?
Amelia Mullett summarises an Australian RCT on the efficacy of a short message service brief contact intervention (SMS-SOS) in reducing repetition of hospital-treated self-harm.
[read the full story...]Anti-inflammatory treatments for youth depression: promising but not yet implementable
Céline Wessa reports on a recent systematic review of pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms, which has some promising results.
[read the full story...]Just how good are antipsychotics at preventing relapse? Bridging the efficacy-effectiveness gap
Samei Huda summarises a new network meta-analysis in the Lancet Psychiatry on the efficacy and effectiveness of antipsychotics for schizophrenia in research settings, such as randomised controlled trials, versus real-world and clinical settings.
[read the full story...]Opening ward doors doesn’t make staff any more coercive
John Baker summarises a new Norwegian trial published last week, which compares an open-door policy to treatment-as-usual in urban psychiatric inpatient wards.
[read the full story...]Risk factors for depression relapse while on long-term maintenance antidepressant treatment
In her debut blog, Asha Ladwa discusses a secondary analysis of data from the ANTLER trial, which investigated the clinical factors associated with relapse in primary care patients on long-term maintenance antidepressants.
[read the full story...]